ACADIA PHARMACEUTICALS INC Uncategorized Contracts & Agreements
31 Contracts & Agreements
- Product Agreement, effective May 1, 2022, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on February 28, 2024)
- Second Amendment to Product Agreement, dated October 6, 2016, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on February 28, 2024)
- Third Amendment to Product Agreement, dated December 11, 2017, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on February 28, 2024)
- First Amendment to Product Agreement, dated April 25, 2016, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on February 28, 2024)
- Third Amendment to Product Agreement, dated December 11, 2017, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on May 6, 2021)
- Second Amendment to Product Agreement, dated October 6, 2016, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on May 6, 2021)
- First Amendment to Product Agreement, dated April 25, 2016, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on May 6, 2021)
- Third Amendment to Product Agreement, dated December 11, 2017, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on February 27, 2018)
- MSA Attachment No.4 (Filed With SEC on August 8, 2017)
- CHANGE ORDER # 1 to MSA Attachment No. 1 [*&***&] (Filed With SEC on February 28, 2017)
- Second Amendment to Product Agreement between Patheon Pharmaceuticals Inc. and ACADIA Pharmaceuticals Inc. (Filed With SEC on November 7, 2016)
- EXHIBIT 1 DEFINITION OF GOOD REASON (Filed With SEC on February 29, 2016)
- ACKNOWLEDGMENT AND ACCEPTANCE (Filed With SEC on May 7, 2015)
- ACADIA Pharmaceuticals Inc. Description of Outside DirectorCompensation Program (Filed With SEC on March 12, 2013)
- AMENDMENT TO (Filed With SEC on March 9, 2010)
- WHEREAS (Filed With SEC on August 5, 2009)
- ACADIA Pharmaceuticals Inc. 5,750,000 Shares (Filed With SEC on April 5, 2007)
- ACADIA Pharmaceuticals Inc. 4,947,229 Shares (Filed With SEC on April 28, 2006)
- AMENDMENT NO. 2 (Filed With SEC on November 14, 2005)
- EXHIBIT B (Filed With SEC on May 10, 2005)
- DEVELOPMENTAGREEMENT (Filed With SEC on May 25, 2004)
- GENERAL AGREEMENT (Filed With SEC on May 19, 2004)
- ACADIA PHARMACEUTICALS INC. (Filed With SEC on May 19, 2004)
- ACADIA PHARMACEUTICALS INC. 2004 EQUITYINCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS ON FEBRUARY 25, 2004 AMENDED BY THE BOARD OF DIRECTORS ON MARCH 12, 2004 (Filed With SEC on May 19, 2004)
- ACADIA Pharmaceuticals Inc. (Filed With SEC on May 19, 2004)
- DEVELOPMENTAGREEMENT (Filed With SEC on May 5, 2004)
- MANAGINGDIRECTOR CONTRACT (Filed With SEC on February 27, 2004)
- FOR RETIREMENTSM100 FIDELITYBASIC PLAN DOCUMENT No. 10 (Filed With SEC on February 27, 2004)
- Amended bythe Board of Directors and Stockholders: April 22, 1999 Amended by the Board of Directors: November 3, 2000 Approved by Stockholders:December 22, 2000 Amended by the... (Filed With SEC on February 27, 2004)
- INDEMNITY AGREEMENT (Filed With SEC on February 27, 2004)
- AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on February 27, 2004)
